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Abstract: A commercial carbon-modified titanium dioxide, KRONOClean 7000, was applied as
a UV(A) and visible-light active photocatalyst to investigate the conversion of the antipsychotic
pharmaceutical chlorpromazine in aqueous phase employing two monochromatic light sources
emitting at wavelengths of 365 and 455 nm. Photocatalytic and photolytic conversion of chlorpromazine
under both anaerobic and aerobic conditions was analyzed using a HPLC-MS technique. Depending
on the irradiation wavelength and presence of oxygen, varying conversion rates and intermediates
revealing different reaction pathways were observed. Upon visible light irradiation under aerobic
conditions, chlorpromazine was only converted in the presence of the photocatalyst. No photocatalytic
conversion of this compound under anaerobic conditions upon visible light irradiation was observed.
Upon UV(A) irradiation, chlorpromazine was successfully converted into its metabolites in both
presence and absence of the photocatalyst. Most importantly, chlorpromazine sulfoxide, a very
persistent metabolite of chlorpromazine, was produced throughout the photolytic and photocatalytic
conversions of chlorpromazine under aerobic conditions. Chlorpromazine sulfoxide was found to be
highly stable under visible light irradiation even in the presence of the photocatalyst. Heterogeneous
photocatalysis under UV(A) irradiation resulted in a slow decrease of the sulfoxide concentration,
however, the required irradiation time for its complete removal was found to be much longer compared
to the removal of chlorpromazine at the same initial concentration.
Keywords: chlorpromazine; chlorpromazine sulfoxide; KRONOClean 7000; visible light-driven
photocatalysis; HPLC-MS
1. Introduction
The presence of pharmaceutical residues is being reported globally in water and wastewater
streams during the past few decades and this issue has become a big concern [1]. As many of
these medicinal compounds are essential in remedial applications for human/animal health,
their consumption cannot be minimized or limited [2,3]. Despite the very low concentrations of
these chemicals in aquatic systems, they result in serious problems in the environment for humans and
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for living organisms, since they are designed in a way to have specific physiological effects on living
organisms [4–6]. Generally, these chemicals have structures which cannot be biologically degraded
by conventional treatment methods [7,8] and therefore, some post-treatment steps are additionally
required for their proper removal [9–11]. Nevertheless, these methods might not be adequate to remove
the large variety of organic compounds present in wastewater. Thus, the effluents of conventional
treatment plants are major sources of chemical discharges into the aquatic system [12].
One of the proposed methods to treat pharmaceutical-rich aquatic streams is the application of
heterogeneous photocatalytic reactions [13,14]. Through this method, the structure of the drugs present
in water and wastewater streams will be decomposed, and as a result, their negative effects on the
environment, especially their toxicity, will be reduced [15]. Recently, solar light driven heterogeneous
photocatalysis in the treatment of contaminated wastewater has been widely investigated [16–21].
TiO2 is the most commonly used photocatalyst in heterogeneous photocatalytic processes. However,
despite its high stability, low toxicity, and low cost, this photocatalyst is not able to absorb the sunlight
efficiently. Only 5% of sunlight can be absorbed by bare TiO2 and the visible part of the solar energy
remains unutilized [22]. Thus, having a visible-light active photocatalyst allows effectively harvesting
and utilizing the solar energy in wastewater treatment.
In order to increase the light absorption by TiO2, some methods have been investigated such
as doping with metal ions or adsorption of compounds acting as sensitizers on the surface of the
photocatalyst. By doping the TiO2 surface with metal ions, the absorption of this photocatalyst will
be altered to higher wavelengths leading to its increased visible light absorption [23–26]. The latter
approach using dyes as a sensitizer is commonly used in dye sensitized solar cells [27,28] as well as in
photocatalytic applications [29–32]. However, due to the adsorption of the dye on the photocatalyst
surface, the absorption spectrum of the photocatalyst will be changed [33]. This by-effect can be
avoided when applying a carbon-based layer on the surface of the photocatalyst as applied for
KRONOClean 7000, the commercially available carbon-modified TiO2, also known as VLP or Kronos
VLP 7000 in the literature [34–36]. KRONOClean 7000 (named in this work as K-7000) is a commercial
carbon-modified TiO2 with no pigmentary properties, produced by Kronos International, Inc. K-7000
is one of the commercially available UV light active photocatalysts which also shows a high activity
in response to visible light. This material is an ultra-fine carbon modified titanium dioxide with
anatase crystal modification in which due to an aromatic carbon-based sensitizer layer, the visible
light can be absorbed [35]. K-7000 is a bimodal anatase that is able to decompose organic pollutants
as well as odors and NOx compounds [34,35]. As reported by the producer, this material has a BET
surface area of 225 m2 g−1 and an average crystallite size of about 15 nm [37]. Detailed characteristic
and morphological studies on this photocatalyst have been reported before [34–36]. Zabek et al.
have shown that by this modification the bandgap position of the photocatalyst did not change
(compared to bare anatase TiO2) while the visible light absorption was increased [35]. K-7000 has
shown a stable photocatalytic activity after three consecutive experimental runs which confirmed its
reusability for visible light-driven photocatalytic applications [36]. Furthermore, the photo-stability of
the sensitizer layer on the TiO2 upon visible irradiation was also proved through eighteen hours of
photo-mineralization of 4-chlorophenol [35].
Antipsychotic drugs are frequently detected among the various categories of pharmaceuticals
contaminating the water system. These drugs are used widely around the world, while their
increased consumption leads to the enhanced release of these compounds and their metabolites into
the environment [38]. One of the most commonly prescribed groups of psychotropic drugs in the
world is called the phenothiazine group [39,40]. Phenothiazine drugs might end up in water or
wastewater streams after their consumption, in the sewage treatment plant effluents, or as effluents
of the pharmaceutical companies [41,42]. Residual traces of these drugs or their transformation
products in aquatic environments with possible ecotoxicological properties have already been detected
and reported [41,43,44]. Generally, the oxidation process of phenothiazines leads to one, two,
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or four-electron oxidation products and the two-electron oxidation product is reported to be the
sulfoxide metabolite [45].
Chlorpromazine hydrochloride, [3-(2-chloro-10H-phenothiazin-10-yl) propyl] dimethylamine
hydrochloride, the most popular compound from the phenothiazine group, is one of the first of its kind
which was released to the pharmaceutical market in 1952 [46]. This compound is photosensitive in
liquid or solid form and its negative effects upon exposure to sunlight in the human body are already
identified [47]. The dechlorinated free radicals produced from irradiation of this compound in the
body react with the DNA and form singlet oxygen [48]. The formation of short-lived radicals causing
genotoxic consequences was indicated as well [49]. Chlorpromazine is known to be converted into its
metabolites upon UV irradiation through demethylation in the N-chain, oxidation of sulfur or nitrogen,
or ring hydroxylation [43,50]. Chlorpromazine absorbs light more strongly at wavelengths shorter than
300 nm and the resulting excited singlet state easily converts into the triplet state. The excited states
either fragment to form radicals or photo-ionize to form radical cations and electrons [51]. The main
metabolite in photolytic transformation of chlorpromazine, namely, chlorpromazine sulfoxide (named
in this work as SFX) is obtained by the direct reaction of chlorpromazine with molecular oxygen [52].
It is also likely to be produced through hydrolysis of the radical cation [53]. Trautwein and Kümmerer
investigated the fate of chlorpromazine and its potential transformation through aerobic and anaerobic
biodegradation as well as abiotic photolytic degradation by sunlight. They observed nearly complete
elimination of chlorpromazine within 4 h of illumination by a xenon arc lamp. They determined
the molecular structures of the three main photolysis products having m/z values of 301, 317,
and 335, through an analysis by high performance liquid chromatography coupled to multiple stage
mass-spectrometry (HPLC–MSn) [43]. In another study, Kigondu et al. evaluated the antimycobacterial
activities of chlorpromazine and its metabolites alone and in combination with antitubercular drugs
in which intermediates with m/z values of 335 and 351 were detected [54]. These compounds were
also reported in an analytical study by Boehme and Strobel in which two HPLC methods have been
introduced to analyze the in vitro metabolism of chlorpromazine [55].
On the other hand, chlorpromazine was reported to show diverse behaviors upon UV irradiation
under aerobic and anaerobic conditions. The photo-induced reaction of chlorpromazine under
anaerobic conditions revealed that polymerization and dimerization processes predominated upon
anaerobic UV photolysis and, interestingly, no evidence of the formation of SFX or other photolytic
products of the aerobic conditions was observed. It was suggested that the free radical cations of
chlorpromazine resulted from cleavage of chloride function from the structure, promotion of these
processes and the polymers were found to be the major products [56].
Despite the extended studies on photolytic degradation of chlorpromazine in aqueous solutions,
to the best of the authors’ knowledge, very little is known about the photocatalytic conversion of this
compound and its metabolites in aqueous systems and their possible removal from water streams.
The photocatalytic conversion of chlorpromazine (in a mixture with two other pharmaceuticals) using
immobilized TiO2 nanoparticles (PC-500) upon UV irradiation was investigated by Khataee et al. [57].
They have reported 90% removal of chlorpromazine in the mixture after 150 min UV irradiation.
However, a detailed mechanistic study was not presented by these authors.
In the current study, photocatalytic and photolytic conversions of chlorpromazine using K-7000
photocatalyst upon UV(A) and visible light irradiation at both anaerobic and aerobic conditions were
studied. Furthermore, the photocatalytic and photolytic transformations of the highly stable metabolite,
SFX, produced under aerobic conditions throughout a long-term irradiation period and its stability
over this process were analyzed.
2. Results and Discussion
In the current study, the conversion of chlorpromazine under photocatalytic conditions as well as
photolytic conditions upon both UV(A) (365 nm) and visible (455 nm) light irradiation was investigated.
KronoClean 7000 (K-7000) was applied as a photocatalyst for conversion of chlorpromazine using
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UV(A) and visible light sources. The experimental runs were performed in the presence and absence
of molecular oxygen at room temperature and natural pH of the suspension. Accordingly, the reaction
intermediates at both photocatalytic and photolytic processes were detected and compared to figure
out the possible reaction pathway for the photocatalytic reaction.
2.1. Photocatalytic and Photolytic Conversion of Chlorpromazine
The photocatalytic and photolytic conversions (C/C0,e) of the probe compound (chlorpromazine)
versus reaction time upon UV(A) and visible light irradiation at, respectively, 365 and 455 nm
wavelengths using K-7000 as photocatalyst in aerobic conditions are presented in Figure 1.
These experimental runs were performed for 180 min, however, in the following graph, only the
first 60 min of irradiation are presented.
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and absence of the photocatalyst. Three main detected products in photolysis upon UV(A) irradiation,
having m/z values of 335, 317, and 301 were also reported for this reaction in similar analytical studies
and for each of these compounds, one or more possible structures have been proposed [43,44,54,55].
Some of the intermediates with significant signal intensities etected thr ugh ut the photocatalytic
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Table 1. Chlorpromazine and some of the reaction intermediates of its photocatalytic and photolytic
conversion under aerobic conditions, their retention times, masses, and possible structures.
Retention Time/min Mass (m/z) Possible Structures (Found as [M + H] +)
19.2 319
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conversions of SFX after 2 h UV(A) irradiation were observed. Furthermore, the comparison between
Figure 5a,b revealed that the produced intermediates throughout the photocatalytic reaction were
completely degraded or converted after 24 h UV(A) irradiation, while in the photolytic reaction,
not only were the produced intermediates not removed after 24 h UV(A) irradiation, but also some
new ones were detected at the end of the reaction.
During the photolytic conversion of SFX upon UV(A) irradiation, the intermediate with the most
intense signal (m/z = 317), was detected at 11.7 min retention time. This signal was increasingly
produced from 15 min to 6 h irradiation and it remained stable until the end of the 24 h UV(A) irradiation.
Another signal at retention time of 15.8 min, corresponding to a combination of m/z = 301 and m/z = 318
was detected from 30 min until 4 h irradiation. Moreover, some new peaks (mainly low intensity
signals) corresponding to m/z = 333, 303, 269, and 287 emerged along the UV(A) irradiation. However,
during the photocatalytic reaction, other detected intermediates after 2 h irradiation corresponding
to m/z = 321 and 250 were completely removed after 24 h UV(A) irradiation. The fact that, under
photocatalytic conditions, much lower concentrations of intermediates were detected indicates that the
photocatalytic process is superior in removal of the produced intermediates compared to the photolytic
process. Analyzing these intermediates suggested different reaction pathways for photocatalytic and
photolytic conversion of SFX over 24 h UV(A) irradiation.
Also upon irradiation with visible light, some differences between the photocatalytic and the
photolytic reactions were observed. Therefore, the intermediates of the photocatalytic and the photolytic
reactions of SFX after 2 h and 24 h of visible irradiation were analyzed and compared as well (Figure 6).
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s served i i re , t r t t e t catalytic reaction upon visible light irradiation,
si ific t difference in the signal inte sity of SFX was detected from 2 h to 24 (only 7% decrease);
revealing that this compound was highly st ble t roughout t e reaction period. During this process,
an evolving small signal at retention time of about 14.4 min (attached to the SFX signal) corresponding
t m/z value of 321 was observed. The intensity of this sig al slightly incre sed over the 24 h visible
light irradiation. Furthermore, throughout the ph tolytic exp riments upon visibl light irradiation,
the signal inte sity of SFX from 2 h t 24 h decreased up to 17%, whil no other intermediates were
detect , confirming that the SFX was highly stable during visible light photolysis.
2.3. Photocatalytic and Photolytic Conversion of Chlorpromazine under Anaerobic Conditions
In addition, the photo-induced intermediates of photolytic and photocatalytic conversions of
chlorpromazine under anaerobic conditions were evaluated. The obtained results are presented in
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Figure 7. It was observed that upon UV(A) irradiation, the rate of chlorpromazine conversion as well as
production rates and types of the intermediates under anaerobic conditions were completely different
from aerobic conditions. However, chlorpromazine was not converted under anaerobic conditions
upon visible light irradiation both in presence and absence of K-7000 and, therefore, no intermediates
were detected for those experimental runs.
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has been also identified under anaerobic c ndit ons by Davies et al. via compar ng the retention factor
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chlorpromazine undergoes a d chlorination step to form free ra icals which then react with the
solvent and produce pr azine and other products [58]. De ec ion f the pro ucts with larges m/z
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2.4. Participation of OH Radicals in the Degradation Pathway of Chlorpromazine
To evaluate the role of hydroxyl radicals throughout the photocatalytic transformation or oxidation
of chlorpromazine and formation of its intermediates or products, an analysis on the amount of produced
hydroxyl radicals upon both UV(A) and visible light irradiation under aerobic conditions in the presence
of K-7000 photocatalyst was performed. Hydroxyl radical is one of the major oxidants in photocatalytic
processes. Throughout a photocatalytic reaction, the formation of hydroxyl radicals on the surface of
the photocatalyst upon irradiation is correlated with photocatalytic conversion of the probe compound
through these radicals generated from photoexcitation of the photocatalyst surface [60]. For this matter,
terephthalic acid was applied as a probe molecule which is known to react specifically with OH radicals
transforming into a fluorescent product, 2-hydroxyterephthalic acid. This reaction product is intensely
fluorescent whereas terephthalic acid itself is non-fluorescent [61]. Irradiating the terephthalic acid
suspension at 315 nm wavelength results in generation of a strong fluorescent signal with a maximum
at around 425 nm. The signal intensity which is directly detected and measured corresponds to the
concentration of the product (2-hydroxyterephthalic acid) in the suspension. Thus, it is possible to
identify the OH radical concentration in the suspension through this method [62].
Accordingly, a suspension of 0.4 mM TA (99%) and 1 mM NaOH with 1 g L−1 photocatalyst
concentration was irradiated for 60 min with UV(A) and visible light. Figure 9 presents the amount of
produced 2-hydroxyterephthalic acid from this suspension upon UV(A) irradiation vs. irradiation
time. Upon visible light irradiation no formation of hydroxyl radicals was observed.
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The photocatalytic experiments of chlorpromazine conversion using K-7000 as photocatalyst, as 
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irradiation were performed. These experiments were carried out in a closed cylindrical borosilicate 
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connected from the top to one of the monochromatic LED light sources emitting at 365 nm (Thorlabs, 
M365L2, 190 mW, 700 mA) or 455 nm (Thorlabs, M455L3, 900 mW, 1000 mA) irradiation wavelengths. 
For each of the LED lamps the photon flux density, N (s−1 cm−2) was calculated through the following 
equation: 
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3. Materials and Methods
3.1. Materials
The commercial carbon-modified titanium dioxide powder (Kronos International, Inc., Leverkusen,
NRW, Germany), KRONOClean 7000 (K-7000), was applied as the photocatalyst in this work.
The commercial chlorpromazine sulfoxide (SFX) was purchased from LGC-Standards (Wesel,
NRW, Germany). Acetonitrile (Rotisolv® HPLC Gradient) was purchased from Carl-Roth (Karlsruhe,
BW, Germany). Chlorpromazine hydrochloride (≥98%), trifluoroacetic acid (spectroscopy Uvasol®),
and all other chemicals in the present study were purchased from Sigma-Aldrich (Merck, Darmstadt,
HE, Germany) (if no additional notation is made). All the chemicals were used as purchased without
further purification. Ultrapure water (≥18.2 MΩ cm) was applied in all the experiments.
3.2. Photocatalytic Procedure
The photocatalytic experiments of chlorpromazine conversion using K-7000 as photocatalyst,
as well as photolysis of chlorpromazine under both UV(A) (365 nm) and visible (455 nm) light irradiation
were performed. These experiments were carried out in a closed cylindrical borosilicate photoreactor
(diameter: 6 cm, height: 3 cm) covered in a shell made of a black polymer which was connected from
the top to one of the monochromatic LED light sources emitting at 365 nm (Thorlabs, M365L2, 190 mW,
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700 mA) or 455 nm (Thorlabs, M455L3, 900 mW, 1000 mA) irradiation wavelengths. For each of the
LED lamps the photon flux density, N (s−1 cm−2) was calculated through the following equation:
N =
λ2∫
λ1
I
E
dλ (1)
The spectral irradiance, I (mW cm−2 nm−1) was measured by a SpectraRad® Xpress (B&W
Tek, Lübeck, SH, Germany)) spectral irradiance meter. E, the energy of a photon with wavelength
λ was calculated by the Planck–Einstein relation [63]. The calculated N value was found to be
1.12 × 1016 s−1 cm−2 for the UV(A) LED lamp (365 nm) and 7.47 × 1016 s−1 cm−2 for the visible light
LED lamp (455 nm). The UV/Vis spectrum of chlorpromazine was recorded employing a UV-visible
Cary-100 spectrophotometer.
For each experimental run, an aqueous suspension containing 100 µM chlorpromazine (or SFX)
and 1 g L−1 photocatalyst was prepared. The reactor was filled with 60 mL of reaction suspension which
was first stirred in the dark for 60 min to ensure the adsorption equilibrium. Clearly, for the photolytic
experiments, the dark period was not required. Subsequently, the suspension was irradiated for
180 min. In aerobic experiments the suspension was purged with oxygen and in anaerobic conditions
the suspension was purged with argon throughout the reaction period. In the case of long-term
experiments, the irradiation time was extended to 24 h. At certain time intervals, samples were
taken from the sampling point provided on the reactor, centrifuged, filtered (PVDF, 0.2 µm pore size),
and finally, the supernatant was obtained and analyzed through HPLC-MS analysis. The results of
these experiments were reported as the conversion of the probe compound calculated from the ratio of
its concentration at a desired reaction time to initial concentration of this compound after equilibrium
(C/C0,e).
3.3. HPLC-MS Analysis
The product distribution was determined by HPLC-UV-MS (ESI) using an Alliance 2795-HT
HPLC (Waters, UK) coupled with a 1050 UV-detector (type 79853C, detection wavelength =254 nm, HP,
USA) and an LCT Premier ESI mass spectrometer (Waters, UK). The chromatography was performed
on an Eurospher II C18 HPLC column (150 * 4 mm, Eurospher II 100-5 C18A, Knauer, Germany)
using water (A) and acetonitril (B), each containing 0.1% trifluoroacetic acid, at a flow rate of 600
µL min−1 with a linear gradient (B%: 15% [0 min], 15% [6 min], 60% [20 min], 60% [23 min], 15%
[26 min]; runtime =35 min). The following relevant MS settings were used: polarity = ESI +; capillary
voltage =2700 V; desolvation temperature =350 ◦C; desolvation gas flow =650 L h−1 (nitrogen); source
temperature =100 ◦C; sample cone voltage =30 V.
3.4. Determination of OH Radicals
In order to detect the possible photocatalytic formation of hydroxyl radicals, the terephthalic acid
(TA) test [33] was performed upon both UV(A) and visible light irradiation wavelengths. Accordingly,
a calibration curve using different concentrations of 2-hydroxyterephthalic acid (97%) was prepared.
To measure the hydroxyl radical formation, a solution of 0.4 mM TA (99%) and 1 mM NaOH was
prepared and the photocatalyst (K-7000) was added to reach a 1 g L−1 concentration in the suspension.
This was followed by a 40 min ultrasonic dispersion step and the suspension was then left in the dark
for 1 h under continuous stirring.
Afterwards, the suspension was divided into two parts which were irradiated separately with the
same UV(A) and visible light sources used for the photocatalytic experiments. Accordingly, at desired
time intervals, samples were taken from these suspensions, centrifuged, and analyzed via a Hitachi
fluorescence spectrophotometer model F-700 recording the emission in the range of 400 to 600 nm
(excitation wavelength =315 nm).
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4. Conclusions
The experimental results of this work revealed that the conversion rate of the probe compound,
chlorpromazine, as well as type and production rates of the reaction intermediates varies using different
irradiation wavelengths. Although chlorpromazine was converted directly upon UV(A) irradiation
into its metabolites, for its conversion upon visible light irradiation, the presence of a visible-light
active photocatalyst was necessary. Furthermore, observation of the products with m/z values of 301
and 285 under anaerobic conditions suggested the reduction of chlorpromazine through electrons and
not the hydroxyl radicals.
A persistent intermediate, namely, chlorpromazine sulfoxide (SFX) was the main reaction
intermediate of visible-light photolytic and photocatalytic conversions of chlorpromazine under aerobic
conditions. Although chlorpromazine was completely converted upon visible-light photocatalysis
within the first 30 min of irradiation, this persistent intermediate, SFX, was highly stable over the 24 h
of constant visible light irradiation even in the presence of K-7000 photocatalyst. This long-lasting
compound was converted extremely slowly over a long-term heterogeneous photocatalytic process
under UV(A) irradiation, however, the required irradiation time for complete removal of SFX was
found to be at least 20 times longer compared to the removal of chlorpromazine at the same initial
concentration. Nevertheless, the photocatalytic and photolytic conversions of SFX were found to
have different reaction pathways. Moreover, throughout the photocatalytic pathway, the reaction
intermediates or metabolites were successfully removed from the reaction medium indicating the
superior ability of the photocatalytic process in the removal of the produced intermediates compared
to the photolytic process.
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